Alaska Permanent Fund Corporation — Full Portfolio
5 tracked investments · listed companies and verified rows first
Dynatrace provides a platform for unified observability, security, and business data analytics across clouds and containers.
AI & Machine LearningCloud ComputingCybersecurityData & InfrastructureDeveloper ToolsEnterprise Software
John Van SicleninRick McConnell(Chief Executive Officer and Director)inJim Benson(Executive Vice President, Chief Financial Officer and Treasurer)inDan Zugelder(Executive Vice President, Chief Revenue Officer)inBernd Greifeneder(Executive Vice President, Chief Technology Officer)inStephen McMahon(Executive Vice President, Chief Customer Officer)
Co-investorsGarage CapitalGrand VenturesRembrandt Venture PartnersSilver Lake PartnersUncorrelated VenturesAccolade Partners+1 more
Generate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering.
AI & Machine LearningBiotechDeep TechSomerville, US
Gevorg Grigoryan(Founder)inMichael Nally(Chief Executive Officer)inAvak Kahvejian(Founder)Geoffrey von Maltzahn(Founder)Molly Gibson(Founder)
Co-investorsFlagship PioneeringAlumni VenturesARCH Venture PartnersMarch Capital PartnersNVIDIAALTITUDE LIFE SCIENCE VENTURES+4 more
Seattle-based cancer immunotherapy company developing CAR-T and TCR cell therapies; acquired by Celgene, now part of Bristol-Myers Squibb.
BiotechSeattle, US
Hans Bishop(Executive Officer, Director, Promoter)Richard Klausner(Director, Promoter)Bernard J. Cassidy(Executive Officer)Robert Azelby(Executive Officer)Sunil Agarwal(Executive Officer)Rupert Vessey(Director)
Co-investorsARCH Venture PartnersBezos ExpeditionsRidgeback CapitalCrestline InvestorsVenrock
Sana is a biotech company developing engineered cell medicines, including gene therapies for gene modification and delivery, cell replacement therapies using stem cell biology, and manufacturing solutions to improve patient access to these treatments.
BiotechHealthtechMedical DevicesSeattle, US
Richard Mulligan(Director)inHans Bishop(Founder)Steve Harr(Founder)James J. MacDonald(Executive Officer)Nathan Hardy(Executive Officer)
BoardGeoffrey von Maltzahn(Director)in
Co-investorsAmerican Family VenturesARCH Venture PartnersCatalytic Impact FoundationF-Prime CapitalFlagship PioneeringGV (Google Ventures)+10 more
Celerion provides clinical pharmacology and bioanalytical services to support pharmaceutical and biotechnology companies in early-phase drug development and regulatory submissions.
BiotechHealthtechLincoln, US
Susan Thornton(Founder and Chief Executive Officer)
Co-investorsBCIKensington Capital Partners Limited
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




















.jpg?itok=YnNGtnt9)



